View of Safety and Efficacy of Tacrolimus Ointment 0.03 % as a Steroid-Sparing Regimen in Patients with Severe or Refractory Vernal Keratoconjunctivitis (VKC): A study from Quetta, Balochistan

Return to Issue Details Safety and Efficacy of Tacrolimus Ointment 0.03 % as a Steroid-Sparing Regimen in Patients with Severe or Refractory Vernal Keratoconjunctivitis (VKC): A study from Quetta, Balochistan Download Download PDF